Literature DB >> 9255793

Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain.

K Nord1, E Gunneriusson, J Ringdahl, S Ståhl, M Uhlén, P A Nygren.   

Abstract

Small protein domains, capable of specific binding to different target proteins have been selected using combinatorial approaches. These binding proteins, called affibodies, were designed by randomization of 13 solvent-accessible surface residues of a stable alpha-helical bacterial receptor domain Z, derived from staphylococcal protein A. Repertoires of mutant Z domain genes were assembled and inserted into a phagemid vector adapted for monovalent phage display. Two libraries, each comprising approximately 4 x 10(7) transformants, were constructed using either an NN(G/T) or an alternative (C/A/G)NN degeneracy. Biopanning against the target proteins Taq DNA polymerase, human insulin, and a human apolipoprotein A-1 variant, showed that in all cases significant enrichments were obtained by the selection procedures. Selected clones were subsequently expressed in Escherichia coli and analyzed by SDS-PAGE, circular dichroism spectroscopy, and binding studies to their respective targets by biospecific interaction analysis. The affibodies have a secondary structure similar to the native Z domain and have micromolar dissociation constants (KD) for their respective targets.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9255793     DOI: 10.1038/nbt0897-772

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  145 in total

1.  Staphylococcal surface display of metal-binding polyhistidyl peptides.

Authors:  P Samuelson; H Wernérus; M Svedberg; S Ståhl
Journal:  Appl Environ Microbiol       Date:  2000-03       Impact factor: 4.792

2.  Mutational analysis of the interaction between albumin-binding domain from streptococcal protein G and human serum albumin.

Authors:  Martin Linhult; Hans Kaspar Binz; Mathias Uhlén; Sophia Hober
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

3.  TEM-1 beta-lactamase as a scaffold for protein recognition and assay.

Authors:  Daniel Legendre; Bénédicte Vucic; Vincent Hougardy; Anne-Lise Girboux; Christophe Henrioul; Julien Van Haute; Patrice Soumillion; Jacques Fastrez
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

4.  Structural basis for recognition by an in vitro evolved affibody.

Authors:  Martin Högbom; Malin Eklund; Per-Ake Nygren; Pär Nordlund
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

5.  An affibody in complex with a target protein: structure and coupled folding.

Authors:  Elisabet Wahlberg; Christofer Lendel; Magnus Helgstrand; Peter Allard; Vildan Dincbas-Renqvist; Anders Hedqvist; Helena Berglund; Per-Ake Nygren; Torleif Härd
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-19       Impact factor: 11.205

6.  Engineered lactic acid bacterium Lactococcus lactis capable of binding antibodies and tumor necrosis factor alpha.

Authors:  Matjaz Ravnikar; Borut Strukelj; Natasa Obermajer; Mojca Lunder; Ales Berlec
Journal:  Appl Environ Microbiol       Date:  2010-08-27       Impact factor: 4.792

Review 7.  Protein-based tumor molecular imaging probes.

Authors:  Xin Lin; Jin Xie; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2010-03-17       Impact factor: 3.520

8.  N-terminal engineering of amyloid-β-binding Affibody molecules yields improved chemical synthesis and higher binding affinity.

Authors:  Joel Lindgren; Anna Wahlström; Jens Danielsson; Natalia Markova; Caroline Ekblad; Astrid Gräslund; Lars Abrahmsén; Amelie Eriksson Karlström; Sebastian K T S Wärmländer
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

Review 9.  Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.

Authors:  J Gustav Smith; Robert E Gerszten
Journal:  Circulation       Date:  2017-04-25       Impact factor: 29.690

10.  Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer.

Authors:  Natalya Belousova; Galina Mikheeva; Juri Gelovani; Victor Krasnykh
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.